Molecular mechanisms for the antitumor activity of inositol hexakisphosphate (IP6)

Cancer Genomics and Proteomics

Volumn 4, Issue 1, 2007, Pages 43-51

  Bozsik, Anikó ^a   Kökény, Szabolcs ^a   Olah, Edith ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

Apoptosis; Cell differentiation; IP6; K 562 leukemia cells; Microarray; Pathway

Indexed keywords

BENZIDINE; PHYTIC ACID; PROTEIN BAX; PROTEIN BCL 2;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA MICROARRAY; DOSE RESPONSE; DRUG MECHANISM; ERYTHROID CELL; GENE EXPRESSION; HEMOGLOBIN SYNTHESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL; NUCLEOTIDE SEQUENCE; PROTEIN FOLDING; REAL TIME POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE; UPREGULATION;

EID: 33947210819     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Harland BF and Oberleas D: Phytate in foods. World Rev Nutr Diet 52: 235-259, 1987.
2. Noboyuki S, Mohamed S and Michael RH: Metabolism and biological activities of inositol pentakisphosphate and inositol hexakisphosphate. Biochemical Pharmacology 50(2): 137-146, 1995.
3. Shears SB: Assessing the omnipotence of inositol hexakisphosphate. Cell Signal 13(3): 151-158, 2001.
4. 6: a review. Anticancer Res 19: 3733-3736, 1999.
5. De Camilli P, Emr SD, McPherson PS and Novick P: Phosphoinositides as regulators in membrane traffic. Science 271(5255): 1533-1539, 1996.
6. Shears SB: Transcriptional regulation: a new dominion for inositol phosphate signaling? BioEssays 22: 786-789, 2000.
7. Hanakahi LA, Bartlet-Jones M, Chappell C, Pappin D and West SC: Binding of inositol phosphate to DNA-PK and stimulation of double-strand break repair. Cell 102(6): 721-729, 2000.
8. 3H]inositol hexaphosphate (phytic acid) is rapidly absorbed and metabolized by murine and human malignant cells in vitro. J Nutr 124(6): 861-868, 1994.
9. Zhang Z, Song Y and Wang X-L: Inositol hexaphosphate-induced enhancement of natural killer cell activity correlates with suppression of colon carcinogenesis in rats. World J Gastroenterol 11(32): 5044-5046, 2005.
10. Shamsuddin AM and Yang GY: Inositol hexaphosphate inhibits growth and induces differentiation of PC-3 human prostate cancer cells. Carcinogenesis 16: 1975-1979, 1995.
11. Wattenberg LW: Chemoprevention of pulmonary carcinogenesis by myo-inositol. Anticancer Res 19: 3659-3662, 1999.
12. 6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line. Anticancer Res 18(6A): 4083-4090, 1998.
13. 6): a novel treatment for pancreatic cancer. J Surg Res 126(2): 199-203, 2005.
14. Shears SB: Transcriptional regulation: a new dominion for inositol phosphate signaling? Bio Essays 22: 786-789, 2000.
15. Berridge M J and Irvine RF: Inositol phosphates and cell signalling. Nature 341: 197-205, 1989.
16. Huang C, Ma W-Y, Hecht SS and Dong Z: Inositol hexaphosphate inhibits cell transformation and activator protein 1 activation by targeting phosphatidylinositol-3′ kinase. Cancer Research 57(14): 2873-2878, 1997.
17. 6: A novel anticancer agent. Life Sciences 61(4): 343-354, 1997.
18. 6 in HT-29 human colon carcinoma cell line. Anticancer Res 18: 1479-1484, 1998.
19. 6) blocks proliferation of human breast cancer cells through a PKCdelta-dependent increase in p27Kip1 and decrease in retinoblastoma protein (pRb) phosphorylation. Breast Cancer Res Treat 91(1): 35-45, 2005.
20. Ferry S, Matsuda M, Yoshida H and Hirata M: Inositol hexakisphosphate blocks tumor cell growth by activating apoptotic machinery as well as by inhibiting the Akt/NFkappaB-mediated cell survival pathway. Carcinogenesis 23(12): 2031-2041, 2002.
21. 6) inhibits key events of cancer metastasis: II Effects on integrins and focal adhesions. Anticancer Res 23(5A): 3681-3689, 2003.
22. 6). Carcinogenesis 25(11): 2115-2123, 2004.
23. Phillippy BQ and Graf E: Antioxidant functions of inositol 1,2,3/trisphosphate and inositol 1,2,3,6-tetrakisphosphate. Free Radic Biol Med 22(6): 939-946, 1997.
24. 3H]-InsP6 receptors. Br J Pharmacol 117(5): 979-985, 1996.
25. Baten A, Ullah A, Tomazic VJ and Shamsuddin AM: Inositol-phosphate- induced enchancement of natural killer cell activity correlates with tumor suppression. Carcinogenesis 10(9): 1595-1598, 1989.
26. Shamsuddin AM, Baten A and Lalwani ND: Effect of inositol hexaphosphate on growth and differentiation in K-562 erythroleukemia cell line. Cancer Lett 64: 195-202, 1992.
27. Morceau F, Dupont C, Palissot V, Borde-Chiche P, Trentesaux C, Dicato M and Diederich M: GTP-mediated differentiation of the human K562 cell line: transient overexpression of GATA-1 and stabilization of gamma-globin mRNA. Leukemia 14(9): 1589-1597, 2000.
28. 6: growth inhibition and differentiation of human mammary cancer cell lines in vitro. Anticancer Res 16(6A): 3287-3292, 1996.
29. 6: a review. Anticancer Res 19(5A): 3733-3736, 1999.
30. Vucenik I, Kalebic T, Tantivejkul K and Shamsuddin AM: Novel anticancer function of inositol hexaphosphate: inhibition of human rhabdomyosarcoma in vitro and in vivo. Anticancer Res 18(3A): 1377-1384, 1998.
31. 6) on human normal and leukaemic hematopoietic cells. Br J Haematol 117: 577-587, 2002.
32. Olah E, Natsumeda Y, Ikegami T, Kote Z, Horanyi M, Szelenyi J, Paulik E, Kremmer T, Hollan SR, Sugar J et al: Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K-562 leukemia cells. Proc Natl Acad Sci USA 17: 6533-6537, 1988.
33. Mi H, Lazareva-Ulitsky B, Loo R, Kejariwal A, Vandergriff J, Rabkin S, Guo N, Muruganujan A, Doremieux O, Campbell MJ, Kitano H and Thomas PD: The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res 1;33(Database issue): D284-288, 2005.
34. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4): 402-408, 2001.
35. Oltvai ZN, Milliman CL and Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog , Bax, that accelerates programmed cell death. Cell 74: 609-619, 1993.
36. Nickel KP and Belury MA: Inositol hexaphosphate reduces 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase independent of protein kinase C isoform expression in keratinocytes. Cancer Letters 140: 105-111, 1999.
37. Polo SE and Almouzni G: Histone metabolic pathways and chromatin assembly factors as proliferation markers. Cancer Letters 220: 1-9, 2005.
38. Harley CB and Villeponteau B: Telomeres and telomerase in aging and cancer. Curr Opin Genet Dev 5: 249-255, 1995.
39. Jagadeesh S and Banerjee PP: Inositol hexaphosphate represses telomerase activity and translocates TERT from the nucleus in mouse and human prostate cancer cells via the deactivation of Akt and PKCα. Biochemical and Biophysical Research Communications, doi:10.1016/j.bbrc.2006.09.002, 2006.
40. Weglarz L, Molin I, Orchel A, Pafiniewitz B and Dzierzewicz Z: Quantitative analysis of the level of p53 and p21(WAF1) mRNA in human colon cancer HT-29 cells treated with inositol hexaphosphate. Acta Biochim Pol 53(2): 349-356, 2006.
41. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA and el-Houseini ME: Induction of p21(WAF-1/CIP1) during differentiation. Oncogene 9(11): 3389-3396, 1994.
42. Rangatia J and Bonnet D: Transient or long-term silencing of BCR-ABL alone induces cell cycle and proliferation arrest, apoptosis and differentiation. Leukemia 20(1): 68-76, 2006.